Latest filing published 19 Feb 2021 for Decibel Therapeutics, Inc., €2.2M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Matthew Foy: trading record in brief
Matthew Foy is a declared insider of Decibel Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 4 filings cover trades dated 17 February 2021.
On the market, this insider has only ever bought: 1 purchase, €2.2M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 19 February 2021: an open-market purchase of €2.2M, in Decibel Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew Foy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ US$18.00100.0% of flowCommon StockSEC:0000899243-21-007444:3Canonical exit: 18 May 2021 (T+90)
- 458,487 sharesCommon StockSEC:0000899243-21-007444:0
- 247,324 sharesCommon StockSEC:0000899243-21-007444:1
- 327,852 sharesCommon StockSEC:0000899243-21-007444:2
4 of 3 declarations
